Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction.


Journal

Microbiological research
ISSN: 1618-0623
Titre abrégé: Microbiol Res
Pays: Germany
ID NLM: 9437794

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 25 04 2022
revised: 24 05 2022
accepted: 22 06 2022
pubmed: 3 7 2022
medline: 15 7 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

Emergence of SARS-CoV-2 VOCs at different time points through COVID-19 pandemic raised concern for increased transmissibility, infectivity and vaccination breakthroughs. 1567 international travellers plus community transmission COVID-19 cases were analysed for mutational profile of VOCS, that led to notable waves in India, namely Alpha, Delta, and Omicron. Spike mutations in Linkage Disequilibrium were investigated for potential impact on structural and functional changes of Spike-ACE2. ORF1ab and spike harboured diverse mutational signatures for each lineage. B.1.617.2 and AY. * demonstrated comparable profile, yet non-clade defining mutations were majorly unique between international vs community samples. Contrarily, Omicron lineages showed substantial overlap in non-clade defining mutations, signifying early phase of transmission and evolution within Indian community. Mutations in LD for Alpha [N501Y, A570D, D1118H, S982A], Delta [P681R, L452R, EFR:156-158 G, D950N, G142D] and Omicron [P681H, D796Y, N764K, N969K, N501Y, S375F] resulted in decreased binding affinity of Spike-ACE2 for Alpha and BA.1 whereas Delta, Omicron and BA.2 demonstrated strong binding. Genomic surveillance tracked spread of VOCs in international travellers' vs community transmission. Behavioural transmission patterns of variants, based on selective advantage incurred by spike mutations, led us to predict sudden takeover of Delta over Alpha and BA.2 over BA.1 in India.

Sections du résumé

BACKGROUND BACKGROUND
Emergence of SARS-CoV-2 VOCs at different time points through COVID-19 pandemic raised concern for increased transmissibility, infectivity and vaccination breakthroughs.
METHODS METHODS
1567 international travellers plus community transmission COVID-19 cases were analysed for mutational profile of VOCS, that led to notable waves in India, namely Alpha, Delta, and Omicron. Spike mutations in Linkage Disequilibrium were investigated for potential impact on structural and functional changes of Spike-ACE2.
RESULTS RESULTS
ORF1ab and spike harboured diverse mutational signatures for each lineage. B.1.617.2 and AY. * demonstrated comparable profile, yet non-clade defining mutations were majorly unique between international vs community samples. Contrarily, Omicron lineages showed substantial overlap in non-clade defining mutations, signifying early phase of transmission and evolution within Indian community. Mutations in LD for Alpha [N501Y, A570D, D1118H, S982A], Delta [P681R, L452R, EFR:156-158 G, D950N, G142D] and Omicron [P681H, D796Y, N764K, N969K, N501Y, S375F] resulted in decreased binding affinity of Spike-ACE2 for Alpha and BA.1 whereas Delta, Omicron and BA.2 demonstrated strong binding.
CONCLUSION CONCLUSIONS
Genomic surveillance tracked spread of VOCs in international travellers' vs community transmission. Behavioural transmission patterns of variants, based on selective advantage incurred by spike mutations, led us to predict sudden takeover of Delta over Alpha and BA.2 over BA.1 in India.

Identifiants

pubmed: 35779308
pii: S0944-5013(22)00139-2
doi: 10.1016/j.micres.2022.127099
pmc: PMC9232397
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127099

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.

Références

Front Genet. 2021 Dec 17;12:753648
pubmed: 34976008
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17513-17515
pubmed: 32632012
J Med Virol. 2022 May;94(5):1825-1832
pubmed: 35023191
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Virus Evol. 2022 Mar 05;8(1):veac017
pubmed: 35371558
Nat Methods. 2015 Aug;12(8):733-5
pubmed: 26076426
Protein Sci. 2018 Jan;27(1):129-134
pubmed: 28875543
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Med Virol. 2022 Apr;94(4):1641-1649
pubmed: 34914115
Int J Surg. 2022 Mar;99:106581
pubmed: 35202859
Methods Mol Biol. 2014;1137:163-79
pubmed: 24573481
EClinicalMedicine. 2021 Jun;36:100915
pubmed: 34095794
Cell Rep. 2022 Apr 26;39(4):110729
pubmed: 35452593
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Nat Med. 2021 Apr;27(4):710-716
pubmed: 33846610
Elife. 2015 Jul 20;4:e07454
pubmed: 26193119
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
PLoS One. 2021 May 25;16(5):e0251368
pubmed: 34033650
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Sci Rep. 2018 Oct 2;8(1):14661
pubmed: 30279585
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Angew Chem Int Ed Engl. 2021 Jul 12;60(29):15870-15878
pubmed: 33860605
Science. 2021 Nov 19;374(6570):995-999
pubmed: 34648303
Front Microbiol. 2022 Mar 03;13:763169
pubmed: 35308382

Auteurs

Priyanka Mehta (P)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Varsha Ravi (V)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Priti Devi (P)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Ranjeet Maurya (R)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Shaista Parveen (S)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Pallavi Mishra (P)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Aanchal Yadav (A)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Aparna Swaminathan (A)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Sheeba Saifi (S)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India.

Kriti Khare (K)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Partha Chattopadhyay (P)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Monika Yadav (M)

Department of Biochemistry, Maharshi Dayanand University, Rohtak, Haryana 124001, India.

Nar Singh Chauhan (NS)

Department of Biochemistry, Maharshi Dayanand University, Rohtak, Haryana 124001, India.

Bansidhar Tarai (B)

Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi 110017, India.

Sandeep Budhiraja (S)

Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi 110017, India.

Uzma Shamim (U)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India. Electronic address: uzma.shamim@igib.in.

Rajesh Pandey (R)

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: rajeshp@igib.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH